Inhibition of telomerase activity enhances hyperthermia-mediated radiosensitization

Cancer Research

Volumn 68, Issue 9, 2008, Pages 3370-3378

  Agarwal, Manjula ^a   Pandita, Shruti ^a   Hunt, Clayton R ^a   Gupta, Arun ^a   Yue, Xuan ^b   Khan, Saira ^a   Pandita, Raj K ^a   Pratt, David ^a   Shay, Jerry W ^c   Taylor, John Stephen A ^b   Pandita, Tej K ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 70; TELOMERASE; TELOMERASE INHIBITOR; TELOMERASE REVERSE TRANSCRIPTASE; ENZYME INHIBITOR; H2AFX PROTEIN, HUMAN; HISTONE; RNA; TELOMERASE RNA;

ARTICLE; CELL KILLING; CELL SURVIVAL; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYPERTHERMIA; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; RADIOSENSITIZATION; ADJUVANT CHEMOTHERAPY; ANIMAL; BIOLOGICAL MODEL; CELL CULTURE; CELL DEATH; DRUG ANTAGONISM; DRUG SCREENING; GENETICS; HEAT; HELA CELL; HYPERTHERMIC THERAPY; METABOLISM; MOUSE; MULTIMODALITY CANCER THERAPY; NEOPLASM;

ANIMALS; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ENZYME INHIBITORS; HEAT; HELA CELLS; HISTONES; HSP70 HEAT-SHOCK PROTEINS; HUMANS; HYPERTHERMIA, INDUCED; MICE; MODELS, BIOLOGICAL; NEOPLASMS; RNA; TELOMERASE; TUMOR STEM CELL ASSAY;

EID: 44849109968     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-5831     Document Type: Article

References (41)

1. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985;43:405-13.
2. Sharma GG, Gupta A, Wang H, et al. hTERT associates with human telomeres and enhances genomic stability and DNA repair. Oncogene 2003;22:131-46.
3. Pandita TK. Role of HSPs and telomerase in radiotherapy. Int J Hyperthermia 2005;21:689-94.
4. Hunt CR, Dix DJ, Sharma GG, et al. Genomic instability and enhanced radiosensitivity in Hsp70.1- and Hsp70.3-deficient mice. Mol Cell Biol 2004;24:899-911.
5. Hunt CR, Pandita RK, Laszlo A, et al. Hyperthermia activates a subset of ataxia-telangiectasia mutated effectors independent of DNA strand breaks and heat shock protein 70 status. Cancer Res 2007;67:3010-7.
6. Gerweck LE, Nygaard TG, Burlett M. Response of cells to hyperthermia under acute and chronic hypoxic conditions. Cancer Res 1979;39:966-72.
7. 2/M cell cycle arrest. Cell Stress Chaperones 2001;6:326-36.
8. Luft JC, Dix DJ. Hsp70 expression and function during embryogenesis. Cell Stress Chaperones 1999;4:162-70.
9. Bukau B, Deuerling E, Pfund C, Craig EA. Getting newly synthesized proteins into shape. Cell 2000;101:119-22.
10. Georgopoulos C, Welch WJ. Role of the major heat shock proteins as molecular chaperones. Annu Rev Cell Biol 1993;9:601-34.
11. Hartl FU. Molecular chaperones in cellular protein folding. Nature 1996;381:571-9.
12. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
13. Pandita TK. Telomeres and telomerase. Encyclopedia of Cancer 2002;4:355-62.
14. Wood LD, Halvorsen TL, Dhar S, et al. Characterization of ataxia telangiectasia fibroblasts with extended life-span through telomerase expression. Oncogene 2001;20:278-88.
15. Yuan X, Ishibashi S, Hatakeyama S, et al. Presence of telomeric G-strand tails in the telomerase catalytic subunit TERT knockout mice. Genes Cells 1999;4:563-72.
16. Chang S, Multani AS, Cabrera NG, et al. Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nat Genet 2004;36:877-82.
17. 2/M checkpoint. EMBO J 2003;22:6610-20.
18. Elayadi AN, Braasch DA, Corey DR. Implications of high-affinity hybridization by locked nucleic acid oligomers for inhibition of human telomerase. Biochemistry 2002;41:9973-81.
19. Herbert BS, Gellert GC, Hochreiter A, et al. Lipid modification of GRN163, an N3′→P5′ thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition. Oncogene 2005;24:5262-8.
20. Jackson SR, Zhu CH, Paulson V, et al. Antiadhesive effects of GRN163L - an oligonucleotide N3′→P5′ thiophosphoramidate targeting telomerase. Cancer Res 2007;67:1121-9.
21. Pandita TK. Role of mammalian Rad9 in genomic stability and ionizing radiation response. Cell Cycle 2006;5:1289-91.
22. Sawant SG, Gregoire V, Dhar S, et al. Telomerase activity as a measure for monitoring radiocurability of tumor cells. FASEB J 1999;13:1047-54.
23. 2-phase-specific cell survival, and homologous recombinational repair. Mol Cell Biol 2006;26:1850-64.
24. Pandita TK, Westphal CH, Anger M, et al. Atm inactivation results in aberrant telomere clustering during meiotic prophase. Mol Cell Biol 1999;19:5096-105.
25. Scherthan H, Jerratsch M, Dhar S, Wang YA, Goff SP, Pandita TK. Meiotic telomere distribution and Sertoli cell nuclear architecture are altered in Atm- and Atmp53-deficient mice. Mol Cell Biol 2000;20:7773-83.
26. Dhar S, Squire JA, Hande MP, Wellinger RJ, Pandita TK. Inactivation of 14-3-3σ influences telomere behavior and ionizing radiation-induced chromosomal instability. Mol Cell Biol 2000;20:7764-72.
27. Pandita TK, Hall EJ, Hei TK, et al. Chromosome end-to-end associations and telomerase activity during cancer progression in human cells after treatment with α-particles simulating radon progeny. Oncogene 1996;13:1423-30.
28. Ferguson AT, Evron E, Umbricht CB, et al. High frequency of hypermethylation at the 14-3-3σ locus leads to gene silencing in breast cancer. Proc Natl Acad Sci U S A 2000;97:6049-54.
29. 2 phase x-irradiation of cells from cancer-prone individuals implicates deficiency in DNA repair. Proc Natl Acad Sci U S A 1983;80:5612-6.
30. Pandita TK, Roti Roti JL. Role of telomerase in radiocurability [review]. Oncol Rep 2003;10:263-70.
31. Forsythe HL, Jarvis JL, Turner JW, Elmore LW, Holt SE. Stable association of hsp90 and p23, but not hsp70, with active human telomerase. J Biol Chem 2001;276:15571-4.
32. Pandita TK. ATM function and telomere stability. Oncogene 2002;21:611-8.
33. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998;279:349-52.
34. Sharma GG, Hall EJ, Dhar S, Gupta A, Rao PH, Pandita TK. Telomere stability correlates with longevity of human beings exposed to ionizing radiations. Oncol Rep 2003;10:1733-6.
35. White LK, Wright WE, Shay JW. Telomerase inhibitors. Trends Biotechnol 2001;19:114-20.
36. Bendifallah N, Rasmussen FW, Zachar V, Ebbesen P, Nielsen PE, Koppelhus U. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA). Bioconjug Chem 2006;17:750-8.
37. Masutomi K, Possemato R, Wong JM, et al. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc Natl Acad Sci U S A 2005;102:8222-7.
38. Vertrees RA, Zwischenberger JB, Boor PJ, Pencil SD. Oncogenic ras results in increased cell kill due to defective thermoprotection in lung cancer cells. Ann Thorac Surg 2000;69:1675-80.
39. Masunaga S, Ono K, Hori H, et al. Modification of tirapazamine-induced cytotoxicity in combination with mild hyperthermia and/or nicotinamide: reference to effect on quiescent tumour cells. Int J Hyperthermia 1999;15:7-16.
40. van der Zee J. Heating the patient: a promising approach? Ann Oncol 2002;13:1173-84.
41. Sharma GG, Hwang KK, Pandita RK, et al. Human heterochromatin protein 1 isoforms HP1(Hsa) and HP1(Hsβ) interfere with hTERT-telomere interactions and correlate with changes in cell growth and response to ionizing radiation. Mol Cell Biol 2003;23:8363-76.